Skip to main content

(Editor's note: The incoming Biden Administration is expected to halt or delay regulations and actions taken under the Trump administration that don't take effect until after Jan. 20. This action could affect the rule discussed in this review. The suspensions are considered standard practice for an incoming administration.)

In this review: Medicare Program; Medicare Coverage of Innovative Technology (MCIT) and Definition of "Reasonable and Necessary" (final rule)
Final Medicare Coverage of Innovative Technology (fact sheet)

Effective date: March 15, 2021

Log in or create a free account to keep reading.

Join APTA to get unlimited access to content.

You Might Also Like...


Noridian Audits Call for Documentation that Could Be Impossible to Provide

Jan 31, 2022

The notices being sent to PTs ask for records more in line with inpatient facilities. Here's what we know — and tips on how to respond.


Code Pairing Edits: Four Things To Know

Jan 25, 2021

APTA successfully advocated for CMS to lift misguided coding edits, and we're working to bring commercial payers around.


CMS Takes Aim at Prior Authorization in Medicaid, CHIP, and Federal Exchanges

Jan 19, 2021

The final rule pushes payers toward more transparency and consistent deadlines for decisions.